At a Glance
  • Status: Completed Consortium
  • Year Launched: 2008
  • Initiating Organization: European Commission’s 7th Framework Programme (FP7)
  • Initiator Type: Government
  • No disease focus
  • Location: Europe


SYBILLA develops new analytical and mathematical tools to generate and integrate high-density quantitative data describing T-cell activation. Proteomics, transcriptomics, imaging, and biochemical techniques will be applied to obtain holistic maps of the T-cell signaling network and to achieve a quantitative and dynamic understanding of signaling networks and their regulation in response to different signal inputs. Building upon already existing schemes of the network connectivity, constant iteration between experiment and mathematical modelling will be used to develop robust and predictive models that describe the functioning of the T-cell signaling network. SYBILLA will allow the identification of new drug targets and the discovery of new biomarkers to refine prognosis of autoimmune diseases.


The goal of SYBILLA is to understand the intracellular network of T cells that determines T cell fate. Through a multidisciplinary effort SYBILLA aims to understand at systems level, how T-cells discriminate foreign- from self-peptides by activating quantitatively distinct signaling pathways. Data obtained in mouse models are extended to human T cells and to a mouse model of multiple sclerosis.   

Structure & Governance

Lead by Dr. Wolfgang Schamel, University of Freiburg, Freiburg, Germany


European Union-funded large integrated project in framework program 7 (FP7).


For a list of SYBILLA scientific publications, click here

Points of Contact

PD Dr. Wolfgang Schamel
Dept. of Molecular Immunology
University Freiburg
Schänzlestr. 18
79104 Freiburg

Tel: +49-(0)761-203-67511
Fax: +49-(0)761-5108-423

Sponsors & Partners

The Signal Transduction Society

The Immunological Genome Project

The Immune Response Consortium

Last Updated: 06/21/2017

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.